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Abstract
Many studies have been published on the relationship between the risk of 
cardiovascular disease and various nutrients, foods, and eating patterns. Despite 
the well-accepted concept that diet has a significant influence on the development 
and prevention of cardiovascular disease, foods considered healthy or harmful have 
varied over the years. Cardiovascular diseases are one of the main causes of illness 
and death in Western countries, and cardiovascular drugs are the most commonly 
used medications. There are two types of factors involved in the development of 
cardiovascular disease. Some factor can be modified, like lifestyle, diet, environ-
ment, or smoking. Others such as genetic factors, gender, history, or age cannot be 
modified. In this chapter, some food, nutrients, and bioactive compounds that are 
susceptible to exert beneficial of harmful properties on cardiovascular disease are 
presented.
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1. Introduction
Diet and healthy lifestyle are the best tools to have good cardiovascular health. 
This relationship is so direct because the majority of cardiovascular diseases 
have their origin atherosclerotic plaque, hypertension, and obesity. These three 
cardiovascular risk factors are directly related to dietary habits and lifestyle. It is 
widely demonstrated from the scientific point of view that dietary habits influ-
ence cardiovascular health. There are diets such as the Dietary Approaches to Stop 
Hypertension (DASH) as the Mediterranean diet, which are clear examples of 
heart-healthy diets. However, there are discrepancies with regard to what are the 
components of a heart-healthy diet. There are foods that are considered healthy 
for the heart in all editions of food guides and recommendations, among which we 
can find fruits, vegetables, and whole grains, which have always been considered 
fundamental for health, and there are other foods that can currently be considered 
heart-healthy, since there are numerous studies that this is supported, such as 
virgin olive oil, pulses, fish, and nuts (especially nuts). This chapter focuses on 
the most recent food evidence (e.g., fruits and vegetables) and nutrients (such as 
fiber and omega-3) considered to be cardio-healthy today and as a counterpoint, 
the scientific clairvoyance that exists on those foods considered less heart-healthy 
because they are considered to increase cardiovascular risk (eggs, dairy products, 
meats, and salt).
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2.  Cardiovascular disease and its association with dietary patterns and 
nutrients
2.1 Meta-analysis related to dietary patterns and cardiovascular disease
Nowadays, most of the evidence supporting the beneficial and harmful effects 
of food and nutrients is based on observational epidemiological studies. The infor-
mation of the present section aims to elucidate the current knowledge about dietary 
patterns and cardiovascular problems. The information is divided in food groups, in 
order to clarify as most as possible.
Fruits and vegetables have traditionally been considered promoting health 
foods. This is due to the association between the greater consumption of these 
products and the reduction of the risk of suffering chronic diseases, such as cardio-
vascular disease (CVD). Consequently, the current dietary guidelines recommend 
an increase in the consumption of fruits and vegetables up to five servings a day [1].
Current evidence is largely based on prospective cohort studies showing 
uniform associations between increased consumption of fruits and vegetables 
and reduced risk of both coronary artery disease (CAD) and stroke. However, 
these studies do not have the highest level of scientific evidence. In contrast, the 
number of controlled intervention trials (which provide a higher level of scientific 
evidence) in which the relationship between fruit and vegetable consumption and 
clinical endpoints has been investigated is unusual. However, the results of these 
studies show associations between increased consumption of fruits and vegetables 
and improvement of blood pressure and microvascular function. Meanwhile, 
associations with plasma lipid concentrations, risk of diabetes mellitus (DM), and 
body weight have not yet been definitely recognized [2].
The dietary habits of English population between 2001 and 2013 have been 
studied and reported in a recent study. It was observed that the consumption (seven 
daily servings of fruits and vegetables) reduces the specific risks of death from 
cancer and heart disease in 25 and 31%, respectively [3]. This report also showed 
that vegetables have a significantly greater beneficial health effect than fruits. It is 
important to emphasize that, whatever the starting point, the data indicate that the 
highest consumption of fruits and vegetables always provides a benefit. In addition, 
many confounding factors, such as poor access to fresh fruits and vegetables for 
people with preexisting health conditions or complicated lifestyles or those living 
in disadvantaged areas, affect the experimental approach used by these researchers. 
In conclusion, as reported by Berciano and Ordovás [2], the evidence indicating 
consumption of fruits and vegetables as dismissal of the risk of CVD is largely 
limited to observational epidemiology. Therefore, new intervention studies will be 
necessary to establish the existing real relationship.
Fruits and vegetables are very rich in both soluble and insoluble fibers, which 
structural and functional characteristics may vary greatly. Insoluble fibers, such as 
cellulose and lignin, are non-hydrolyzable and hardly undergo fermentation, while 
soluble fibers, such as pectin or inulin, are not hydrolyzed in the stomach but can 
be fermented by the gut microbiota. The main physiological effect associated with 
the consumption of insoluble fibers is the reduction of intestinal transit time which 
allows water retention, promotes an increase in fecal mass, and facilitates the move-
ment of food through the intestine, due to mechanical stimulation of the intestinal 
walls. The distension caused also increases the feeling of fullness and can contribute 
to reducing caloric intake [4].
On the other hand, the main physicochemical properties of the soluble fibers 
that characterize their effects are viscosity, the ability to form gels, and fermentabil-
ity. The increase in viscosity slows gastric emptying (which contributes to satiety) 
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and increases transit time. This helps to produce the stabilization of the glucose and 
insulin response and reduces the absorption of dietary cholesterol [4].
Regarding CVD, the most important property of dietary fiber is fermentability 
that reduces the concentration of low-density lipoproteins (LDL) in the blood. 
The mechanism is mediated by short-chain fatty acids produced by colon bacteria. 
Apart from this effect, there are other important considerations related to the lym-
phocyte activation, the inhibition of cell proliferation and the anti-inflammatory 
effects and the bile acid binding activity exerted by the dietary fiber, which act as a 
kidnapper [5]. Despite knowing the different properties and effects on health that 
may have the various types and origins of fiber, most studies have provided insuf-
ficient data, which prevents an independent assessment of the associated risks of 
disease. However, total fiber intake is uniformly associated with a small reduction in 
the risk of CVD, coronary disease (CD), and stroke [6].
All existing reviews conclude that diets rich in fiber are significantly associated 
with lower risk of stroke, CVD, and CD. This inverse association reinforces what is 
indicated in the current guidelines, which recommend an increase in fiber consump-
tion, although studies that have described results related to fractions of fiber are 
too scarce to establish specific recommendations on soluble/insoluble fiber and the 
types of origins of those fibers. Dose-response analyses have identified cutoff values 
that have not been validated and appear to show wide differences between differ-
ent types of fiber. The broader study on this topic indicates that the existence of a 
threshold effect has not been verified and that the message to be retained must be 
rather than the greater the consumption of fiber, the greater the protection [2, 5, 6].
In the last years, coffee has been relegated to the background with the boom 
in tea consumption. Green tea is considered a healthy drink and consumed 
worldwide and has been attributed various beneficial effects to its regular intake, 
such as reducing the risk of suffering from diseases ranging from certain cancers 
to dementia and obesity. With regard to CVD, regular consumption of green tea 
has been associated with small reductions in CVD risk factors, such as LDL and 
blood pressure, which may have clinical relevance [7]. However, the number of 
studies reviewed is too low to be able to draw definitive conclusions, and there is a 
significant lack of long-term follow-up data and cardiovascular events to assess the 
long-term effects of green tea consumption.
Similar to green tea, wine and coffee are two beverages containing a wide variety 
of phytochemical substances that have been associated with a protective effect 
against heart disease. Although these compounds, mostly polyphenols, have been 
intensively studied over the past two decades, the main effects of wine (or alcoholic 
beverages in general) and coffee consumption continue to be attributed to ethanol 
and caffeine, respectively [8]. Recent reviews indicate that beer and especially red 
wine [7, 8] are associated with a greater reduction in the risk of CVD due to its high 
polyphenol content [9, 10]. The protective effects of coffee against CVD are not 
well established. In fact, a moderate consumption of coffee (two to four cups a day) 
has not shown any adverse effects in the long term [2]. However, it is well known 
that an excessive consumption of caffeine leads to hypertension, and in particular 
unfiltered coffee contributes to elevate the serum concentration of LDL, total cho-
lesterol, and triglycerides [11]. It is important to note that the mentioned effects are 
subject to interpersonal differences, since there are many genetic polymorphisms 
that are known to affect different enzymes that are involved in their metabolism [2].
Regarding animal food, blue fish (like other many high-fat foods), such as olive 
oil, was on the list of “unhealthy” foods because of its high-fat content. However, 
from the earliest 1970s, omega-3 fats from blue fish were reported as beneficial to 
health and especially to health related to CVD [12]. However, there are still wide 
discrepancies regarding their effects on optimal doses, as well as their relationship 
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with omega-6 fatty acids or other components of the diet. In fact, the results of 
the published randomized clinical trials (a total of 48 studies that included 36,913 
individuals) have not shown a reduction in the risk of total mortality or the set 
of cardiovascular events in people who take supplementary omega-3 fats [2]. 
Consequently, despite the known effect of omega-3 fat on plasma triglyceride 
concentrations, there is no unequivocal evidence that omega-3 fats in the diet or 
supplements modify total mortality or the set of cardiovascular events. In fact, a 
recent study [13] raises certain doubts about the validity of the premises used to 
support the initial hypothesis on omega-3 and CVD [14].
Continuing with foods of animal origin, one of the most ancient are eggs, which 
were introduced in the diet prior to the appearance in the evolution of Homo sapiens. 
It is not surprising that eggs are an important source of nutrients such as proteins, 
unsaturated fats, fat-soluble vitamins, folate, choline, and minerals. The possible 
counterpoint derives from the fact that, on average, an egg contains 200 mg of 
cholesterol, one-third of the recommended daily amount. The rationale for this 
recommendation continues to be linked to the diet-heart hypothesis. In contrast, 
epidemiological evidence has consistently shown that it is unlikely that the consump-
tion of one egg a day has any significant impact on the risk of CVD in healthy people.
Similarly, the relationship between egg consumption and the clinically relevant 
elevation of plasma cholesterol concentrations is too old. Newer studies revealed 
the actual hypothesis about egg consumption. One of the most recent studies is the 
HELENA study, showing that egg consumption was not associated with the lipid 
profile, adiposity, insulin resistance, blood pressure, good cardiorespiratory func-
tion, or the integrated CVD risk score [15]. In general, current evidence supports 
that egg consumption is not associated with risk of CVD, CD, or cardiac death in 
the general population and may even have a protective value against hemorrhagic 
stroke [16].
In contrast, egg consumption may be associated with an increase in the inci-
dence of type 2 diabetes mellitus in the general population and the comorbidity of 
CVD in diabetic patients [17]. Consequently, it seems that the most recent results 
exonerate the eggs from their intended role of significant dietary factor of the 
CVD epidemic. In this regard, it is important to bear in mind that the absorption of 
cholesterol has great interindividual differences, and only a fifth of the population 
can respond with increases in plasma cholesterol to the presence of cholesterol in 
the diet [17]. Therefore, it is important to identify the genetic determinants of this 
variability.
Regarding meat, scientific literature has been focused on the relationship 
between diet meat, CVD, and total mortality, which have led to a situation less 
clear than in the case of egg consumption. What seems to be clear is the association 
between red meat consumption and total mortality related to CVD, as well as the 
risk of CVD, ischemic stroke, and type 2 diabetes mellitus.
However, this association can often be caused by the consumption of processed 
meats and not always by fresh red meat. In fact, it has been pointed out that the 
harmful effects observed by processed meat may be related to other components, 
such as sodium, nitrites, heme iron, and l-carnitine. For example, the effects of 
elevating blood pressure associated with the high sodium content of processed 
foods could explain the increased risk of people sensitive to salt. There is recent 
evidence reporting that trimethylamine, phosphatidylcholine, choline, and l- 
carnitine in processed and red meat can promote CVD [18]. The scientific literature 
indicates that the consumption of unprocessed red meat and processed red meat 
is not beneficial for cardiometabolic health. In fact, it can be observed that clinical 
and public health guidelines prioritize above all the reduction of consumption of 
processed meat.
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Finally, other foods demonized in recent years are dairy products, in part due 
to their relatively high content of saturated fats and cholesterol. Consequently, 
after having occupied for decades a prominent place among recommended foods, 
dairy products also suffered the consequences of the “non-healthy anti-saturated 
fat fever.” However, this group of foods had a relatively easy way out, and the dairy 
industry started to produce a whole range of low-fat products. As observed by 
Berciano and Ordovás [2], these products already have enough time on the market 
to evaluate them regarding the intrinsic benefits in terms of CVD compared to more 
traditional varieties.
The comparison between fatty and non-fatty dairy products is important 
because the relationship between CVD and saturated fats may not be as simple as 
initially thought. That fact can be due to multiple reasons.
First, not all fats would be the same and were, in origin, classified as good 
(unsaturated) and bad (saturated). However, actual knowledge seems to discuss 
that theory. In fact, it was appreciated that “healthy” fats as polyunsaturated fats 
omega-6 could not be as good as thought. Contrariwise, some of the “bad fats” 
could be healthy (the case of fats saturated from dairy foods) [19].
Second, the replacement of saturated fats in the diet with simple carbohydrates 
has led to an increase in obesity and health complications. Therefore, it is probable 
that some of the adverse effects associated with saturated fats in the past must be 
factors other than saturated fats. Thus, in recent times the relationship between 
dairy foods and the risk of CVD has been revisited on multiple occasions [19]. In 
an interesting study, Huth and Park [20] reviewed the published evidence on milk 
products with milk fat content and cardiovascular health. The results of this review 
indicate that most of the observational studies found no association between the 
consumption of dairy products and increased risk of CVD, CD, and stroke, regard-
less of the concentration of fat in the milk.
In general, it can be concluded that the consumption of dairy products provides 
protection against CVD or, at least, has no adverse effects. Consequently, the exist-
ing data support the concept that milk and low-fat milk products contribute to the 
prevention of hypertension and reduce the risk of stroke and, potentially, other 
CVD events. Another review revised the scientific literature related to observational 
studies on the relationship between the fat of dairy products and high-fat dairy 
foods, obesity, and cardiometabolic disease [21]. Of a total of 16 studies, in 68% 
there was an inverse association between the consumption of high-fat dairy products 
and the parameters of assessment of adiposity. In fact, studies conducted to examine 
the relationship between the consumption of high-fat dairy products and metabolic 
health has described an inverse association or no association [21]. Consequently, 
these results indicate that milk fat or high-fat dairy foods do not contribute to obesity 
or cardiometabolic risk and imply that the consumption of high-fat dairy products 
within the usual dietary patterns has an inverse association with the obesity risk.
3. Oxidative stress and antioxidants
It is commonly accepted by scientific community that oxidative stress is within 
the base of the etiology of cardiovascular diseases. However, the understanding of 
the role of reactive oxygen and nitrogen species (RONS) has evolved somewhat. 
They are not further seen in a whole negative perspective, but current knowledge 
supports that they are generated as part of normal metabolism, as well as a defense 
mechanism of cells from immune system to combat against infections; besides, they 
are implicated in intracellular signaling pathways [22]. Hence, low concentrations 
seem protective by triggering defense mechanisms that prevent cellular damage [23].
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The levels of RONS are counteracted by cellular defenses in the form of anti-
oxidants, to maintain an adequate balanced oxidative status. However, when an 
imbalance in the production/elimination of these reactive species occurs, a specific 
cellular function can be altered [24].
The excess of free radicals attacks macromolecules, mainly polyunsaturated 
fatty acids (PUFA) of cell membranes [25] that leads to cell death and conducts to 
different pathological conditions, as vascular diseases. Oxidation of PUFA generates 
fatty acid radicals, which adds oxygen to form fatty acid peroxyl radicals. These 
radicals can further oxidize PUFA molecules and initiate new chain reactions, 
producing lipid hydroperoxides that can produce more radical species [25].
Oxidative stress contributes markedly to endothelial dysfunction, with a 
reduced activity of nitric oxide (NO). NO induces vasodilation, inhibits platelet 
aggregation, prevents LDL oxidation, and decreases production of proinflamma-
tory cytokines. Free radicals oxidize and inactivate NO impeding its protective 
action. Besides, vascular cells generate reactive species principally by NADPH 
oxidase pathway [26]. The increased NADPH oxidase activity and the decrease in 
antioxidant enzyme defenses and cysteine/cystine redox potential increase the risk 
of cardiovascular disease [22].
Free radicals induce the expression of adhesion molecules in vascular wall, as 
intercellular adhesion molecule 1 (ICAM-1), what activates the migration of mono-
cytes and T cells to the vessel [27] and helps to their attachment to the endothelial 
surface. The oxidation of low-density lipoproteins (LDL) by free radicals is followed 
by their uptake by macrophages. Macrophage cells are converted into foam cells, accu-
mulating in the wall and further activating cells from the immune system, perpetuat-
ing the damage. This is the hallmark of initiation of the process of atherosclerosis.
These oxidative changes can be prevented/ameliorated or mitigated by antioxi-
dants. From a chemical point of view, antioxidants are molecules able to react with 
oxidative species, as free radicals, thus preventing oxidation of a third molecule. Based 
on their nature, antioxidants have been classified as enzymatic and nonenzymatic 
forms. Enzymes that break down and remove free radicals include superoxide dis-
mutase (SOD), catalase (CAT), and glutathione peroxidase (GPx). SOD converts the 
superoxide radical O2
•− into O2 and H2O2 in the presence of metal ion cofactors as cop-
per, zinc, or manganese. CAT converts H2O2 in H2O and O2, and GPx converts H2O2 to 
H2O and fatty acid hydroperoxides to their corresponding alcohol forms. All of them 
show synergistic effect and play the major role in prevention of oxidative damage [25].
Low molecular weight antioxidants react due to one-electron reactions with 
free radicals and possess a chemical structure able to delocalize the one electron 
that resulted. They form relative stable radicals by delocalization of the unpaired 
electron within their structure. The term includes both endogenous (glutathione, 
uric acid, bilirubin) and exogenous antioxidants from dietary origin (ascorbic acid, 
α-tocopherol, carotenoids, and polyphenols, among others).
α-Tocopherol is the main antioxidant in lipid environment, as it scavenges lipid 
peroxides in cell membranes and lipid particles, including low-density lipoprotein 
(LDL), forming an α-tocopheroxyl radical. It intercepts lipid peroxyl radicals and 
terminates lipid peroxidation reactions [25].
Vitamin C has been considered the most important water-soluble antioxidant 
in extracellular environment. It scavenges various RONS and regenerates the 
α-tocopheroxyl radical back to tocopherol [28]. It forms ascorbyl radical, and two 
molecules react rapidly to produce one molecule of ascorbate and one molecule of 
dehydroascorbate.
Dietary polyphenols behave as scavenging antioxidants due to their chemical 
structure of benzo-ɣ-pyrene cycle. They are able to delocalize the unpaired electron 
formed after the reaction with free radicals, as they possess an ortho-dihydroxy 
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structure in the B-ring and a [2, 3] double bond in conjugation, as well as the 
4-hydroxyl function in C ring. Besides, they can chelate metal ions implicated in the 
generation of free radicals [29].
Epidemiological studies have shown that a regular intake of fruits and veg-
etables, rich in antioxidants, reduces the risk of degenerative diseases and cancer 
[30]. Animal models and in vitro studies performed with particular antioxidants 
have supported this point of view. There is a generalized and accepted idea that the 
excessive production of free radicals causes damage and that the scavenging of these 
radicals is health protective. Hence, a number of human clinical trials on different 
populations with antioxidant supplementation were performed some decades ago. 
However, they showed non-antioxidant effects or even negative outcomes [31]. A 
meta-analysis of more than 300,000 individuals showed no prevention of cardio-
vascular disease after supplementation with vitamins E, C, and A and an increased 
risk of cancer in smokers with β-carotene supplementation [32]. Antioxidants have 
failed to prevent or delay the development of atherosclerosis [33, 34].
It must be pointed out that most in vitro and animal models used pharmacologi-
cal doses of antioxidants in imposed oxidative stress conditions, far from the real 
physiological situation [35].
The contradictory results obtained in the human intervention studies prompted 
the investigators to undertake a better understanding toward the mechanisms of 
antioxidants to maintain a balanced redox status.
The classic perception of antioxidants as free radical scavengers has evolved to 
their action on cell signaling to stimulate enzymatic antioxidant protection. In fact, 
most free radicals and electrophile species are removed through enzymatic reac-
tions using reducing power in the form of NADPH, GSH, and reduced thioredoxin 
[36]. Moreover, free radicals are extremely reactive within the cell, and the most 
effective protection mechanism is to prevent their formation, by enzyme-catalyzed 
reactions, rather than trying to scavenge them once formed. Catalase dismutates 
H2O2 to H2O and O2, and peroxidase reduces hydroperoxides using GSH. The only 
possible biologically relevant antioxidant able to react with hydroxyperoxyl radicals 
is α-tocopherol [37]. Its subsequent radical formed, and the α-tocopheroxyl radical 
is reduced back by ascorbic acid [25].
Cells are able to adapt its redox potential increasing antioxidant enzymes, 
leading to transcription factors that act as redox sensors. Some antioxidants pos-
sess hormetic actions by upregulating the expression and activity of antioxidant 
defense enzymes, as well as by activating endothelial nitric oxide synthase (eNOS) 
that increases NO production and hence ameliorates vascular tone. The reaction 
of phytochemical antioxidants with free radicals gives oxidized products that are 
involved in signal transduction pathways. The last consequence is the activation of 
enzyme antioxidant activity and repair systems. Enzyme-catalyzed reactions occur 
at higher reaction rates than free radical scavenging by exogenous antioxidants.
One of the main pathways involved is nuclear factor erythroid 2-related factor 
2 (Nrf2). Nrf2 is linked to the protein Keap 1 and remains inactive in the cytosol 
until Keap1 is oxidized. Nrf2 then translocates to nucleus where it activates ARE 
genes. The activation of the Nrf2 transcription factor and the antioxidant response 
element (ARE) to which Nrf2 binds conducts to the transcription of genes encoding 
phase II detoxification enzymes.
Reports about the activation of this signaling pathway by compounds within 
the diet are increasing recently. Dietary soy has shown to inhibit atherosclerotic 
lesion progression by a mechanism that involves this Nrf2 gene transcription. Other 
phytochemicals include curcumin from turmeric [38], diallyl sulfide from garlic 
[39], isothiocyanates as sulforaphane from broccoli [40], and polyphenols from 
apple [41].
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These mechanistic studies have been performed with pure compounds, and it is 
conceivable that supplementation with antioxidants in concentrations that saturate 
this system can exert none or even harmful effects [24]. Hence, it is advisable to 
provide an adequate level of antioxidants by nutritional intake to regulate the 
antioxidant system in a physiological basis.
4. Bioactive compounds
“Bioactive compounds” are extranutritional constituents that typically occur in 
small quantities in foods. Epidemiological studies have demonstrated that nutritional 
habits, like those based on high consumption of foods rich in bioactive substances 
(natural products derived from plants, marine organisms, and animals), have been 
associated with a longer life expectancy and a significant decrease in the incidence and 
prevalence of several chronic diseases with inflammatory basis, such as CVD [42].
These bioactive compounds possess a wide range of biological activities includ-
ing antitumor, anti-inflammatory, anticarcinogenic, antiviral, antimicrobial, 
antidiarrheal, antioxidant, and other activities [43].
Dietary supplementation with bioactive natural compounds demonstrated that 
lipid-lowering effects (cholesterol synthesis inhibitors, intestinal cholesterol absorp-
tion inhibitors, and LDL-C excretion stimulants) are currently supported by the inter-
national guidelines for CVD prevention and some international expert panels [44].
4.1 Omega-3
The functions of the fatty acids are diverse. In addition to their energetic value, 
they are also part of the phospholipids found in the membranes of the body’s cells 
and determine in a greater or lesser extent the structure and functionality of the 
cell. Such functionality refers to aspects like fluidity and permeability, lipid peroxi-
dation, etc. [45]. Experimental, epidemiological, and interventional studies have 
demonstrated the beneficial cardiovascular effects of eicosapentaenoic acid (EPA) 
and docosahexaenoic acid (DHA), which have anti-atherosclerotic, antithrombotic, 
antiarrhythmic, and anti-inflammatory effects.
Food contains omega-3 fatty acids in three main active forms: eicosapentaenoic 
acid (20: 5 omega 3, EPA), docosahexaenoic acid (22: 6 omega-3, DHA) and alpha-
linolenic acid (18: 3 omega-3, a-ALA). EPA and DHA forms can be found in fish 
oils, fish that mainly live in cold waters such as salmon, tuna, and sardines, among 
other varieties. EPA, DHA, and ALA are essential fatty acids, and they need to be 
ingested in the diet, since the body cannot synthesize them [46].
In a study, it was showed that the intake of EPA and DHA is inversely related to 
cardiovascular risk in a dose-dependent manner up to about 250 mg/day in healthy 
populations, and the intake of 1 g/day is associated with a marked protection from 
a sudden cardiac death [47]. The daily recommended intake of omega-3 fatty acids 
varies from 250 mg to 1 g of EPA and DHA.
4.2 Polyphenols
Polyphenols are bioactive compounds that can be found mostly in foods like 
fruits, cereals, vegetables, dry legumes, and chocolate and beverages such as coffee, 
tea, and wine. They are extensively used in the prevention and treatment of cardio-
vascular disease (CVD) providing protection against many chronic illnesses [48].
Polyphenols can regulate cellular lipid metabolism, vascular and endothe-
lial function, hemostasis, as well as platelet function, which represent primary 
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conditions for atherosclerotic plaque formation and development. The cardiopro-
tective effects of polyphenols have been linked mainly to its antioxidant properties; 
however, recent findings attribute its anti-atherosclerotic potential to modulate 
simultaneous signaling and mechanistic pathways [42]. Recently, the PREDIMED 
study reported that dietary polyphenols intake such as extra-virgin olive oil and 
nuts were associated with improved CVD risk factors and decreased inflammatory 
biomarker levels in high-CVD-risk participants [49].
Moreover, polyphenols alter hepatic cholesterol absorption, triglyceride bio-
synthesis and lipoprotein secretion, the processing of lipoproteins in plasma, and 
inflammation [48]. A recent study showed that polyphenols intake decreased blood 
pressure (BP), increased plasma high-density lipoprotein (HDL) and decreased 
the inflammatory biomarkers of CVD, including vascular cell adhesion molecule 
1 (VCAM-1), intercellular adhesion molecule 1 (ICAM-1), IL-6, TNF-α as well as 
MCP-1. Treatment with quercetin ameliorated the high-fat diet-induced MetS such 
as abdominal obesity, cardiovascular remodeling, and liver complications in rats 
by increasing the expression of Nrf2, HO-1, and carnitine palmitoyltransferase 1 
(CPT1) and decreasing NF-κB [50].
Finally, it has been reported that the effects of polyphenols on human health 
depend on the amount consumed and on their bioavailability.
4.3 Phytosterols
Phytosterols are bioactive compounds found in foods of plant origin, which 
can be divided into plant sterols and plant stanols. Food sources of phytosterols 
include vegetable oils, mainly corn (909 mg/100 mL), sunflower (411 mg/100 mL), 
soybean (320 mg/100 mL), and olive (300 mg/100 mL); oleaginous fruits such 
as almonds (183 mg/100 g); cereals like wheat germ (344 mg/100 g) and wheat 
bran (200 mg/100 g); and in addition fruits and vegetables, such as passion fruit 
(44 mg/100 g), orange (24 mg/100 g), and cauliflower (40 mg/100 g) [51].
Clinical studies consistently indicate that the intake of phytosterols (2 g/day) is 
associated with a significant reduction (8–10%) in levels of low-density lipoprotein 
cholesterol (LDL-cholesterol). A typical Western diet contains approximately 
300 mg of sterols and 30 mg of plant stanols, while vegetarian diets can achieve 
a higher content (300–500 mg/day). Phytosterols intake based on regular diets is 
considered too low to achieve their recommended daily intake -which are able to 
present therapeutic effects on LDL-cholesterol reduction-, (~2 g/day),  
and the consumption of foods enriched with phytosterols or, alternatively, the use 
of supplements of phytosterol are generally required [52].
In the last decades, purified plant sterols or stanols have been added to various 
food items to obtain functional foods with remarkable hypocholesterolemic activity. 
A daily intake of plant sterols or stanols of 1.6–2 g/day, incorporated in these foods, 
is able to reduce cholesterol absorption from the gut by about 30% and plasma 
LDL-cholesterol levels by 8–10% [53].
Most guidelines and consensus on the treatment of dyslipidemia and/or preven-
tion of CVD recommend the intake of phytosterols in the amount of approximately 
2 g/day with the goal of reducing LDL-cholesterol by approximately 10%, in 
association with lifestyle changes [54].
4.4 Hydroxytyrosol
Hydroxytyrosol, 2-(3,4-dihydroxyphenyl)-ethanol (OHTYR), is a phenolic com-
pound present in the fruit and leaf of the olive (Olea europaea L.), which belongs 
to the family Oleaceae, comprising species distributed throughout the temperate 
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regions of the world, and essentially localized in the Mediterranean basin. Another 
natural source of OHTYR is red wine [55]. In fact, daily intake of hydroxytyrosol in 
the Mediterranean area would be 2 mg (considering the maximum 50 mg/day). This 
amount would be insufficient to reach the recommended amount of 5 mg to develop 
the benefit of protection of LDL particles from oxidative damage [56].
Numerous human and animal studies have shown that olive polyphenols, par-
ticularly hydroxytyrosol, can improve blood cholesterol profiles and reduce the risk 
of potentially lethal thrombosis [57]. Hydroxytyrosol can be considered antithrom-
botic, since it significantly reduces platelet aggregation [58].
Various authors support the potential beneficial effects of hydroxytyrosol in 
atherogenesis through the reduction of LDL oxidation. In addition to hydroxytyro-
sol, oleuropein has also been shown to effectively inhibit LDL oxidation induced by 
copper sulfate [59].
4.5 Melatonin
Melatonin (N-acetyl-5-methoxytryptamine) is a neuroendocrine hormone, which 
is synthesized primarily by the pineal gland. The synthesis and secretion of melatonin 
are regulated by light intensity [60]. Melatonin-rich foods include various food com-
ponents from both animal and plant origins such as chicken, lamb, pork, cow milk, 
strawberries, tomatoes, olives, grapes, wines, cereals, and cherries. Interestingly, 
melatonin concentrations are significantly higher in plants than in animals [61].
Importantly, recent research suggests that melatonin plays an important role in 
various cardiovascular diseases, including myocardial ischemia-reperfusion injury, 
atherosclerosis, hypertension, heart failure, drug-induced myocardial injury, pulmo-
nary hypertension, vascular diseases, valvular heart diseases, and lipid metabolism.
Early experiments showed that treatment with melatonin can improve dyslip-
idemia. In patients with nonalcoholic fatty liver disease, treatment with melatonin 
(2 × 5 mg/day) for 14 months significantly reduced levels of triglycerides and LDL-
cholesterol (LDL-C) compared with controls [62].
Yang et al. [63] demonstrated that melatonin reduces flow shear stress-induced 
bone marrow mesenchymal stem cell injury by acting on melatonin receptors and 
the adenosine monophosphate-activated protein kinase/acetyl-CoA carboxylase 
signaling pathway. These findings suggest that targeting melatonin relating sig-
naling in tissue-engineered heart valves may be an effective strategy in treating 
valvular heart disease.
Melatonin may improve vascular dysfunction by affecting epigenetic regulation. 
In mice generated with assisted reproductive technologies, treatment with melato-
nin resulted in decreased arterial hypertension, which was thought to be due to its 
effects on normalizing nitric oxide levels by preventing impaired methylation of 
endothelial nitric oxide synthase [64].
Borghi and Cicero [65] confirmed the blood pressure (BP)-lowering effects 
of melatonin. It was shown that patients treated with melatonin (2–5 mg/day for 
7–90 days) had a decrease in nocturnal SBP as well as DBP. Additionally, it was 
demonstrated that the effect of melatonin on decreasing BP was most pronounced 
from 3:00 am to 8:00 am [66].
Pulmonary hypertension is a disease characterized by elevated pulmonary 
arterial pressure, which leads to right ventricular hypertrophy and failure. Various 
authors reported that treatment with melatonin alleviated right ventricular hyper-
trophy and dysfunction and also reduced interstitial fibrosis and plasma oxidative 
stress in a rat model of pulmonary hypertension [67].
As an inexpensive and well-tolerated drug, melatonin may be a new therapeutic 
option for cardiovascular disease [54].
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5. Conclusions
There is a clear relationship between diet and cardiovascular health. A heart-
healthy diet should contain fruits and vegetables, which are rich in fiber and 
bioactive compounds. Foods rich in omega-3 fatty acids such as nuts or blue fish 
should not be missing from this diet. There is no scientific evidence relating egg 
or daily products consumption with increased cardiovascular risk (CVR). In fact, 
dairy products protects against CVR. Finally, consumption of processed meats is 
related to increased CVR, due to its high salt content. In fact, dietary guidelines 
recommend the reduction consumption of these processed meats.
On the other hand, given that oxidative stress is the basis of CVD, a diet rich 
in antioxidants may be useful in prevention. Among the antioxidants we must 
highlight the α-tocopherols, vitamin C, and the polyphenols present in fruits and 
vegetables. However, supplementation has not been shown to have preventive 
effects on CVD.
Both omega-3, polyphenols, and phytosterols have been shown to decrease CVR 
factors and inflammatory markers in patients with elevated CVR.
Finally, we must highlight the hydroxytyrosol and melatonin, which are 
involved in the reduction of LDL oxidation and in the improvement of dyslipid-
emia, respectively.
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